Suven Pharmaceuticals Faces Market Volatility Amidst Strong Yearly Gains and Premium Valuation
Suven Pharmaceuticals, with a market capitalization of Rs 26,676.00 crore, has seen significant stock fluctuations today. The company boasts a high P/E ratio of 98.21, indicating premium valuation. Despite a strong annual performance, recent trading shows declines, highlighting ongoing market volatility and mixed technical indicators.
Suven Pharmaceuticals, a prominent player in the Pharmaceuticals & Drugs industry, has experienced notable fluctuations in its stock performance today. With a market capitalization of Rs 26,676.00 crore, the company operates within the large-cap segment. Currently, Suven Pharmaceuticals has a price-to-earnings (P/E) ratio of 98.21, significantly higher than the industry average of 34.86, indicating a premium valuation relative to its peers.Over the past year, Suven Pharmaceuticals has shown a robust performance, with a gain of 65.17%, outpacing the Sensex, which recorded a 13.44% increase. However, recent trends reveal a decline of 1.36% in today's trading session, contrasting with the Sensex's rise of 3.74%. The stock has also faced challenges over the past week and month, with declines of 7.36% and 6.94%, respectively.
In terms of technical indicators, the weekly MACD and moving averages suggest bearish trends, while the monthly KST indicates a bullish outlook. Overall, Suven Pharmaceuticals continues to navigate a complex market landscape, reflecting both its strong historical performance and current volatility.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
